Cargando…
Targeting TKI-Activated NFKB2-MIF/CXCLs-CXCR2 Signaling Pathways in FLT3 Mutated Acute Myeloid Leukemia Reduced Blast Viability
Disease relapse is a common cause of treatment failure in FMS-like tyrosine kinase 3 (FLT3) mutated acute myeloid leukemia (AML). In this study, to identify therapeutic targets responsible for the survival and proliferation of leukemic cells (blasts) with FLT3 mutations after gilteritinib (GILT, a 2...
Autores principales: | Cao, Huynh, Tadros, Verena, Hiramoto, Benjamin, Leeper, Kevin, Hino, Christopher, Xiao, Jeffrey, Pham, Bryan, Kim, Do Hyun, Reeves, Mark E., Chen, Chien-Shing, Zhong, Jiang F., Zhang, Ke K., Xie, Linglin, Wasnik, Samiksha, Baylink, David J., Xu, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138861/ https://www.ncbi.nlm.nih.gov/pubmed/35625776 http://dx.doi.org/10.3390/biomedicines10051038 |
Ejemplares similares
-
Transient TKI-resistant CD44+pBAD+ blasts undergo intrinsic homeostatic adaptation to promote the survival of acute myeloid leukemia in vitro
por: Xu, Yi, et al.
Publicado: (2023) -
Inhibition of CXCLs/CXCR2 axis in the tumor microenvironment might be a potent therapeutics for pancreatic cancer
por: Ijichi, Hideaki
Publicado: (2012) -
FBP1-Altered Carbohydrate Metabolism Reduces Leukemic Viability through Activating P53 and Modulating the Mitochondrial Quality Control System In Vitro
por: Xu, Yi, et al.
Publicado: (2022) -
Vitamin D as a Potential Therapy for Multiple Sclerosis: Where Are We?
por: Wasnik, Samiksha, et al.
Publicado: (2020) -
Inflammation- and Gut-Homing Macrophages, Engineered to De Novo Overexpress Active Vitamin D, Promoted the Regenerative Function of Intestinal Stem Cells
por: Xu, Yi, et al.
Publicado: (2021)